# Bristol-Myers Squibb Company (BMY) — Q1-2012 Earnings Results

**Report date:** 2012-04-26 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q1-2012

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS — Stock Down 1.55%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.64 | N/A | +5.09% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting the company's commitment to its product pipeline. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value through our pipeline.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Bristol Myers Squibb's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 1.55%. This drop may reflect investor concerns over the lack of revenue data and future guidance, which could impact confidence in the company's growth prospects.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q1-2012_